´ëÇѽɺÎÀüÇÐȸ Heart Failure Jeju 2020 : 2020-02-29±³À°ÀÏÀÚ : 2020-02-29
±³À°Àå¼Ò : ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦
±³À°ÁÖÁ¦ :
Heart Failure Jeju 2020ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽɺÎÀüÇÐȸ
´ã´çÀÚ : ±è¿ì¸®
¿¬¶ôó : 02-3275-5335
À̸ÞÀÏ :
khfs2@khfs.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
Á¦ÁÖƯº°ÀÚÄ¡µµ±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 09:00~09:15 The Energetic Coupling of the Left Ventricle and Arterial System in HF Patients ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 09:15~09:30 PCWP vs LVEDP as a Prognostic Factor in HF Patients ¾çÁ¤ÈÆ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 09:30~09:45 Invasive and Non-invasive Hemodynamic Indexes for RV Failure ±è¹Î¼®(¿ï»êÀÇ´ë)
Åä·Ð 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 09:45~10:15 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 02-29 10:15~10:30 Coffee Break ()
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 10:30~11:45 Remodeling and Reverse Remodeling of LV ¿ÀÀç¿ø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 10:45~11:00 Atrial Remodeling in HFpEF ¹Ú¼º¹Ì(°í·ÁÀÇ´ë)
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 11:00~11:15 LVAD Induced Reverse Remodeling °ÁöÈÆ(¼¿ïÀÇ´ë)
Åä·Ð 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 11:15~11:45 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
½Ä»ç 02-29 11:45~12:45 Lunch ()
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 12:45~13:00 Strain in HF ¹ÚÀçÇü(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 13:00~13:15 AI in Image of Heart Á¶Á¤¼±(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 13:15~13:40 Role of Nuclear Medicine for Infiltrative Cardiac Disease ÀÌ¿ø¿ì(¼¿ïÀÇ´ë)
Åä·Ð 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 13:40~13:55 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 13:55~14:20 How to Interpret the Result of Target Sequencing in Cardiomyopathies (esp. How to Interpret the Result) ±èº¸¶÷(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 14:20~14:45 How to Design and Perform Genomic Studies for Cardiovascular Disease Using Exome Sequencing ¿øÈ«Èñ(¼º±Õ°ü´ëÇб³ »ï¼ºÀ¶ÇÕÀÇ°úÇпø)
Åä·Ð 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 14:45~15:00 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 02-29 15:00~15:15 Coffee Break ()
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 15:15~15:30 Case 1 ¹ÚÀ±Áö(°í·ÁÀÇ´ë)
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 15:30~15:45 Case 2 ¹Úº¸Àº(°æºÏÀÇ´ë)
±³À°½Ã°£ 02-29 ¸ÞÁ¾±Û·¡µå Á¦ÁÖ 2Ãþ Å©¸®½ºÅ»È¦ 15:45~16:00 Case 3 ±è°æÁø(ÀÌÈÀÇ´ë)